Clinical Trials Logo

Mental Disorders clinical trials

View clinical trials related to Mental Disorders.

Filter by:

NCT ID: NCT05756855 Recruiting - Schizophrenia Clinical Trials

Young Adults With Violent Behavior During Early Psychosis

Start date: March 19, 2024
Phase: N/A
Study type: Interventional

This study aims to provide an evidence-based behavioral intervention to reduce violent behavior for individuals experiencing early psychosis.

NCT ID: NCT05753423 Recruiting - Clinical trials for Mental Health Disorder

Impact of Maternal Mental Health on the Oral Health Status and Oral Health-related Quality of Life of Their Children

Start date: May 8, 2022
Phase:
Study type: Observational

Dental caries is a complex multifactorial disease that is strongly related to and influenced by the children's dietary habits, sugar intake, salivary flow, salivary fluoride level, and preventive behaviors. Based on the literature, other factors can affect child dental caries including the influence of social factors, such as the family environment. To avoid suffering from dental caries, preventive oral hygiene practices beginning in childhood are crucial. However, parents are the primary providers of oral health care for their children and they generally play a pivotal role in the overall health and oral health of both children and adolescents. Therefore, this study aims to investigate the impact of maternal mental health in the form of depression, anxiety, or stress and their perceived social support on the oral health status and OHRQoL of their children.

NCT ID: NCT05745896 Not yet recruiting - COVID-19 Pandemic Clinical Trials

A Telemedicine Prenatal Care Model on Low Risk Pregnants: The m@Mae-e Study

m@mae-e
Start date: July 1, 2023
Phase: N/A
Study type: Interventional

This study will compare the effectiveness of a prenatal care supported by telemedicine against usual care in low-risk pregnant women. The investigators will follow-up women in a gestational age of 6 weeks up to 41 weeks, and 6 postpartum weeks. The primary outcome is the anxiety level estimated by the General Anxiety Scale 7 scale (GAD-7 Scale).

NCT ID: NCT05742893 Completed - Psychotic Disorders Clinical Trials

Comparison of a Speech-Language Assessment Tool for Pragmatic and Discourse Skills in Schizophrenia Spectrum Disorders

VEOS
Start date: March 6, 2023
Phase: N/A
Study type: Interventional

The scientific literature has largely objectified language disorders in schizophrenia. And more precisely, the impairment of pragmatic and discursive language skills. Currently, there is no standardized language assessment tool specific to these patients. The aim of this study is to compare the effectiveness of a newly developed speech-language assessment tool for pragmatic and discourse skills for patients suffering from schizophrenia .

NCT ID: NCT05738486 Recruiting - Dementia Clinical Trials

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

Start date: February 28, 2023
Phase: Phase 3
Study type: Interventional

This study will investigate different donanemab dosing regimens and their effect on the frequency and severity of ARIA-E in adults with early symptomatic Alzheimer's disease (AD) and explore participant characteristics that might predict risk of ARIA.

NCT ID: NCT05737966 Completed - Clinical trials for First Episode Psychosis

Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist

CHECKLISTPEP
Start date: February 1, 2023
Phase:
Study type: Observational

Psychotic disorders are often chronic conditions that lead to impaired functioning, quality of life and social integration. Current research and recommendations for good practice are moving towards early detection and intervention. It is recognized that this leads to better adherence, alliance to care and knowledge of pathology for the patient, especially in young patients. For more than a decade, early intervention services (EIS) are opened in France over an increasingly large territory. Still too few studies assess the impact of these structures in France. These EIS offer a multimodal intervention (social, professional, psychotherapeutic). The intervention of case managers (or care coordinators in french) seems to be the core of EIS. The case manager has a fundamental role in the process of recovery in coordinating each individual's treatment and ensuring continuity of care. The PEPsy-CM study aims to evaluate the effectiveness on the relapse rate of a 3 year Program for Early Psychosis based on Case Management (PEPsy-CM) compared to TAU in a population of young people with a FEP. A qualitative evaluation of case management practice in EIS seems essential to assess the impact of case managers under real conditions. Based on the Australian Good Practice Recommendations (EPICC integrity tools) and the case management practice manuals, the PEPsy-CM check-list questionnaire was developed to evaluate the practice of case management in the EIS in France. This check-list contains different 35 items. The final score between 1(poor) to 5 (good) is established to determine the quality of the case management. Qualitative data are also collected during the interview with the participants.

NCT ID: NCT05732740 Completed - Depression Clinical Trials

Empower@Home:Connected - Feasibility and Preliminary Effect Study

Start date: January 17, 2023
Phase: N/A
Study type: Interventional

This single-group trial will evaluate the feasibility and preliminary effect of a novel group-based cognitive behavioral therapy program for older adults with elevated depressive symptoms. Participants will complete the program remotely in small groups.

NCT ID: NCT05731414 Not yet recruiting - Schizophrenia Clinical Trials

Outcomes From Remediation and Behavioural Intervention Techniques

ORBIT
Start date: March 1, 2023
Phase: N/A
Study type: Interventional

It is currently unknown what factors predict response to Cognitive Behavioural Therapy for Psychosis (CBTp) or Cognitive Remediation Therapy (CR) among individuals with schizophrenia-spectrum disorders, thus the current trial will examine predictors of response to determine who requires the combined intervention and who might respond sufficiently to either monotherapy.

NCT ID: NCT05731102 Completed - Clinical trials for Substance Use Disorders

Diagnostic Survey of Mental and Substance Use Disorders Among Norwegian College and University Students

Start date: January 24, 2023
Phase:
Study type: Observational

The aims of this observational survey are to 1) collect data on the prevalence of mental and substance use disorders, and 2) investigate risk factors and consequences of mental and substance use disorder

NCT ID: NCT05728138 Recruiting - Clinical trials for Self Harm, First Episode Psychosis

Psychosocial Intervention for Suicidal Ideation in Individuals With FEP: A Feasibility Trial

CMAP-FEP
Start date: November 1, 2023
Phase: N/A
Study type: Interventional

To check the feasibility and acceptability of Culturally adapted Cognitive Behavioral Therapy for Psychosis (CaCBTp) and Culturally Adapted Manual Assisted Brief Psychological Intervention for Self-harm (CMAP), which we have provisionally called (CMAP Plus) for individuals experiencing Suicidal Ideation (SI) in First Episode Psychosis (FEP).